-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Kr82p8qDV+k5khQrQlIYhVNWmssK/9AZPkxYPaRlbSakgBNAIBlx2L1LWx59RTwa 0x4k0SyhTXhsIHWYmY6xrQ== 0000891554-98-000706.txt : 19980612 0000891554-98-000706.hdr.sgml : 19980612 ACCESSION NUMBER: 0000891554-98-000706 CONFORMED SUBMISSION TYPE: SC 13D/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 19980611 SROS: NASD SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: COOPER LIFE SCIENCES INC CENTRAL INDEX KEY: 0000759718 STANDARD INDUSTRIAL CLASSIFICATION: INVESTORS, NEC [6799] IRS NUMBER: 942563513 STATE OF INCORPORATION: DE FISCAL YEAR END: 1031 FILING VALUES: FORM TYPE: SC 13D/A SEC ACT: SEC FILE NUMBER: 005-38037 FILM NUMBER: 98646217 BUSINESS ADDRESS: STREET 1: 160 BROADWAY CITY: NEW YORK STATE: NY ZIP: 10038 BUSINESS PHONE: 2127915362 MAIL ADDRESS: STREET 1: 160 BROADWAY CITY: NEW YORK STATE: NY ZIP: 10038 FORMER COMPANY: FORMER CONFORMED NAME: COOPER LASERSONICS INC DATE OF NAME CHANGE: 19880608 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: MARX MOSES CENTRAL INDEX KEY: 0000941992 STANDARD INDUSTRIAL CLASSIFICATION: [] FILING VALUES: FORM TYPE: SC 13D/A BUSINESS ADDRESS: STREET 1: 160 BROADWAY CITY: NEW YORK STATE: NY ZIP: 10038 BUSINESS PHONE: 2123492875 MAIL ADDRESS: STREET 1: 160 BROADWAY CITY: NEW YORK STATE: NY ZIP: 10038 SC 13D/A 1 AMENDMENT NO. 11 SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13D (Rule 13d-101) UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 11) COOPER LIFE SCIENCES, INC. (Name of Issuer) COMMON STOCK (Title of Class of Securities) 216712109 (CUSIP Number) Emanuel J. Adler Tenzer Greenblatt LLP 405 Lexington Avenue New York, New York 10174 (212) 885-5565 (Name, Address and Telephone Number of Person Authorized to Receive Notice and Communications) May 18, 1998 (Date of Event which Requires Filing of this Statement) If the filing person has previously filed a statement on Schedule 13G to report the acquisition which is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1(b)(3) or (4), check the following box |_|. Note: Six copies of this statement, including all exhibits, should be filed with the Commission. See Rule 13d- 1(a) for other parties to whom copies are to be sent. - ---------- (1) The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). Page 1 of 6 Pages SCHEDULE 13D - -------------------------------------------------------------------------------- CUSIP NO. 216712109 Page 2 of 6 Pages - -------------------------------------------------------------------------------- - -------------------------------------------------------------------------------- 1 NAME OF REPORTING PERSON S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON MOSES MARX - -------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a)|_| (b)|_| - -------------------------------------------------------------------------------- 3 SEC USE ONLY - -------------------------------------------------------------------------------- 4 SOURCE OF FUNDS* N/A - -------------------------------------------------------------------------------- 5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) |_| - -------------------------------------------------------------------------------- 6 CITIZENSHIP OR PLACE OF ORGANIZATION UNITED STATES - -------------------------------------------------------------------------------- 7 SOLE VOTING POWER NUMBER OF 1,106,120* SHARES BENEFICIALLY ------------------------------------------------------------- OWNED BY 8 SHARED VOTING POWER EACH REPORTING ---- PERSON ------------------------------------------------------------- WITH 9 SOLE DISPOSITIVE POWER 1,106,120* ------------------------------------------------------------- 10 SHARED DISPOSITIVE POWER ---- - -------------------------------------------------------------------------------- 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,106,120* - -------------------------------------------------------------------------------- 12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES* |_| - -------------------------------------------------------------------------------- 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 52% - -------------------------------------------------------------------------------- 14 TYPE OF REPORTING PERSON* IN - -------------------------------------------------------------------------------- *SEE INSTRUCTIONS BEFORE FILLING OUT! INCLUDE BOTH SIDES OF THE COVER PAGE, RESPONSES TO ITEM 1-7 (INCLUDING EXHIBITS) OF THE SCHEDULE, AND THE SIGNATURE ATTESTATION. - -------------------- * Includes 125,000 shares of Common Stock reported herein as also being beneficially owned by Momar Corp. Page 2 of 6 Pages SCHEDULE 13D - -------------------------------------------------------------------------------- CUSIP NO. 216712109 Page 3 of 6 Pages - -------------------------------------------------------------------------------- 1 NAME OF REPORTING PERSON S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON MOMAR CORP. - -------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) |_| (b) |_| - -------------------------------------------------------------------------------- 3 SEC USE ONLY - -------------------------------------------------------------------------------- 4 SOURCE OF FUNDS* N/A - -------------------------------------------------------------------------------- 5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) |_| - -------------------------------------------------------------------------------- 6 CITIZENSHIP OR PLACE OF ORGANIZATION MARYLAND - -------------------------------------------------------------------------------- 7 SOLE VOTING POWER NUMBER OF 125,000 SHARES ------------------------------------------------------------- BENEFICIALLY 8 SHARED VOTING POWER OWNED BY EACH ---- REPORTING PERSON ------------------------------------------------------------- WITH 9 SOLE DISPOSITIVE POWER 125,000 ------------------------------------------------------------- 10 SHARED DISPOSITIVE POWER ---- - -------------------------------------------------------------------------------- 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 125,000 - -------------------------------------------------------------------------------- 12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES* |_| - -------------------------------------------------------------------------------- 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 5.87% - -------------------------------------------------------------------------------- 14 TYPE OF REPORTING PERSON* CO - -------------------------------------------------------------------------------- *SEE INSTRUCTIONS BEFORE FILLING OUT! INCLUDE BOTH SIDES OF THE COVER PAGE, RESPONSES TO ITEM 1-7 (INCLUDING EXHIBITS) OF THE SCHEDULE, AND THE SIGNATURE ATTESTATION. Page 3 of 6 Pages This Amendment No. 11 amends and supplements the Schedule 13D, as amended and supplemented by Amendments Nos. 1 through 10, inclusive (the "Schedule 13D"), heretofore filed by the Reporting Persons with the Securities and Exchange Commission with respect to the Common Stock ("Common Stock") of Cooper Life Sciences, Inc., a Delaware corporation (the "Company"). Except as amended hereby, there has been no change in the information contained in the Schedule 13D. Item 5. Interest in Securities of the Issuer. (a) - (b) According to the Company's Quarterly Report on Form 10- Q for the period ending January 31, 1998, there were 2,126,265 shares of Common Stock outstanding on March 13, 1998. Moses Marx As of the date of this Amendment No. 11 Moses Marx beneficially owned 1,106,120 shares of Common Stock, representing 52% (calculated in accordance with the instructions to Schedule 13D) of the issued and outstanding shares of the Common Stock. Said securities consist of (i) 980,620 shares owned directly by Mr. Marx; (ii) 125,000 shares owned of record by Momar; and (iii) 500 options to purchase 500 shares of Common Stock. With respect to the shares described in clause (ii), Mr. Marx may be deemed to be a beneficial owner of such shares by virtue of his being the only person in a position to determine the investment and voting decisions of Momar with respect to such shares. Mr. Marx has the sole power to vote and dispose of all such shares. Page 4 of 6 Pages Momar Momar owns 125,000 shares of Common Stock, comprising 5.87% of the issued and outstanding shares of the Common Stock. Momar has the sole power to vote and dispose of all such shares. (c) On May 18, 1998, Mr. Marx donated 100,000 shares of Common Stock to Terumah Foundation, a 501(c)(3) tax exempt organization. Other than as set forth above, during the last 60 days, neither Mr. Marx nor Momar effected any transactions in the Shares. (d) Each of the Reporting Persons affirms that no person other than the Reporting Persons has the right to receive, or the power to direct the receipt of dividends from, or the proceeds from the sale of, the Common Stock owned by the Reporting Persons. (e) It is inapplicable for the purposes herein to state the date on which the Reporting Persons ceased to be the owners of more than five percent of the Common Stock. Page 5 of 6 Pages SIGNATURE After reasonable inquiry, and to the best of our knowledge and belief, the undersigned certify that the information set forth in this statement is true, complete and correct. Date: June 10, 1998 /s/ Moses Marx ---------------------------------- MOSES MARX MOMAR CORP. By: /s/ Moses Marx ----------------------------- Moses Marx, President Page 6 of 6 Pages -----END PRIVACY-ENHANCED MESSAGE-----